| 
                                 1. Kuo B, Urma D. Esophagus-anatomy and development. GI Motility. 2006 May Available from: https://www.nature.com/gimo/contents/pt1/full/gimo6.html doi:10.1038/gimo6 2. Ott DJ. Motility disorders of the esophagus. Radiol Clin North Am. 1994;32(6):1117-34. 3. Khan FM. Gibbons JP. Khan's the physics of radiation therapy: Lippincott Williams & Wilkins; 2014. 4. Bhide S, Newbold K, Harrington K, Nutting C. Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol. 2012;85(1013):487-94. [ DOI:10.1259/bjr/85942136]  [ PMID]  [ ]  5. Nair CK, Parida DK, Nomura T. Radioprotectors in radiotherapy. J Radiat Res. 2001;42(1):21-37. [ DOI:10.1269/jrr.42.21]  [ PMID]  6. Lederman M. The early history of radiotherapy:1895-1939. Int J of Radiat Oncol Biol Phys. 1981;7(5):639-48. [ DOI:10.1016/0360-3016(81)90379-5]  [ PMID]  7. Dantigny R, Tanty A, Fourneret P, Genin N, Bayet-Papin B, Mousseau M, et al. Prevalence of pain in radiotherapy and improvement of its management. Bulletin du cancer. 2018;105(12):1183-92. [ DOI:10.1016/j.bulcan.2018.08.011]  [ PMID]  8. Hubenak JR, Zhang Q, Branch CD, Kronowitz SJ. Mechanisms of injury to normal tissue after radiotherapy: a review. Plast Reconstr Surg. 2014;133(1):49-56. [ DOI:10.1097/01.prs.0000440818.23647.0b]  [ PMID]  [ ]  9. Attix FH. Introduction to radiological physics and radiation dosimetry: John Wiley & Sons; 2008. 10. Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10(7):718-26. [ DOI:10.1016/S1470-2045(09)70082-8]  [ PMID]  11. Murro D, Jakate S. Radiation esophagitis. Arch Pathol Lab Med. 2015;139(6):827-30. [ DOI:10.5858/arpa.2014-0111-RS]  [ PMID]  12. Hirota S, Tsujino K, Hishikawa Y, Watanabe H, Kono K, Soejima T, et al. Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother Oncol. 2001;58(3):273-8. [ DOI:10.1016/S0167-8140(00)00274-7]  [ PMID]  13. Yamashita H, Takenaka R, Omori M, Imae T, Okuma K, Ohtomo K, et al. Involved-field radiotherapy (IFRT) versus elective nodal irradiation(ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study. Radiation Oncology. 2015;10(1):1-10. [ DOI:10.1186/s13014-015-0482-9]  [ PMID]  [ ]  14. Wada K, Kishi N, Kanayama N, Hirata T, Ueda Y, Kawaguchi Y, et al. Predictors of acute radiation esophagitis in non-small cell lung cancer patients treated with accelerated hyperfractionated chemoradiotherapy. Anticancer research. 2019;39(1):491-7. [ DOI:10.21873/anticanres.13139]  [ PMID]  15. Bardley J, Movsas B. Radiation esophagitis: predictive factors and preventative strategies. Semin Radiat Oncol. 2004;14:280-6. [ DOI:10.1016/j.semradonc.2004.06.003]  [ PMID]  16. West K, Schneider M, Wright C, Collins RB, Coburn N, Tiver K, et al. Radiation-induced oesophagitis in breast cancer: Factors influencing onset and severity for patients receiving supraclavicular nodal irradiation. J Med Imaging Radiat Oncol. 2020;64(1):113-119. [ DOI:10.1111/1754-9485.12943]  [ PMID]  17. Amer MH. Genetic factors and breast cancer laterality. Cancer management and research. 2014;6:191. [ DOI:10.2147/CMAR.S60006]  [ PMID]  [ ]   
                                 |